| Identification | |
| Name: | Nelfinavir mesylate |
| Synonyms: | Nelfinavir nesylate;[(3S-(3R*,4aR*,8aR*,2S*,3S*)]-2-[2-Hydroxy-3-phenylthiomethyl-4-aza-5-oxo-5-(2-methyl-3-hydroxy-phenyl)pentyl]-decahydroisoquinoline-3-N-t-butylcarboxamide methanesulfonic acid);3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S,4aS,8aS)-;Nelfinavir mesylate (USAN);3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S,4aS,8aS)-, monomethanesulfonate (salt);Nelfinavir mesilate (JAN);(3S,4aS,8aS)-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-phenylsulfanyl-butyl]-N-tert-butyl-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide;NLF;AG1343 (*Mesylate salt*);(3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide;AG 1343;Nelfinavir [INN:BAN];3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S-(2-(2S*,3S*),3-alpha,4a-beta,8a-beta))-;3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S-(2(2,S*,3S*),3-alpha,4a-beta,8a-beta))-, monomethanesulfonate (salt);Viracept (TN);N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide (3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-; |
| CAS: | 159989-65-8 |
| Molecular Weight: | 567.7824 |
| InChI: | InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1 |
| Molecular Structure: | ![(甲磺酸奈非那韦) Nelfinavir nesylate;[(3S-(3R*,4aR*,8aR*,2S*,3S*)]-2-[2-Hydroxy-3-phenylthiomethyl-4-aza-5-oxo-5-(2-m...](https://img1.guidechem.com/chem/e/dict/159/159989-65-8.jpg) |
| Properties | |
| Water Solubility: | Practically insoluble in water and soluble in methanol R. |
| Solubility: | Practically insoluble in water and soluble in methanol R. |
| Appearance: | A white or almost white powder. |
| Biological Activity: | Orally active human immunodeficiency virus protease inhibitor. Potently inhibits HIV-1 protease (K i = 2 nM) in vitro . |
| Usage: | An antiviral |
| Safety Data | |
 |
|
